{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:32:57Z","timestamp":1787761977557,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>Lichenoid drug eruptions are a type of skin reaction that is caused by medication and mimics idiopathic lichen planus. Various medications have been known to cause lichenoid drug eruptions, such as antibiotics, anti-convulsants, anti-diabetics, anti-malarials, anti-tubercular drugs, anti-hypertensives, psychiatric drugs, chemotherapeutic agents, diuretics, heavy metals, and non-steroidal anti-inflammatory drugs. Various cutaneous side effects have been reported in association with teriflunomide. We present the case of a patient who developed a lichenoid eruption because of teriflunomide. The dermatologists and neurologists should be aware of these skin side effects.<\/jats:p>","DOI":"10.4103\/aian.aian_27_23","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:01:53Z","timestamp":1686747713000},"page":"275-277","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Lichenoid Drug Eruption Induced by Teriflunomide"],"prefix":"10.4103","volume":"26","author":[{"given":"Fatima-Zahra","family":"Agharbi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Sheikh Khalifa Hospital, Faculty of Medicine, Mohamed VI University of Health Sciences, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehanne","family":"Aasfara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sheikh Khalifa Hospital, Faculty of Medicine, Mohamed VI University of Health Sciences, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenza","family":"Oqbani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sheikh Khalifa Hospital, Faculty of Medicine, Mohamed VI University of Health Sciences, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalqui","family":"Slamti","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sheikh Khalifa Hospital, Faculty of Medicine, Mohamed VI University of Health Sciences, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumiya","family":"Chiheb","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sheikh Khalifa Hospital, Faculty of Medicine, Mohamed VI University of Health Sciences, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"R1-20240828","first-page":"152","article-title":"Cutaneous side effects of first\/second line oral disease-modifying treatments in patients with multiple sclerosis","volume":"1","author":"Arslan","year":"2020","journal-title":"J Exp Neurol"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/15563650.2019.1581940","article-title":"Psoriasiform eruption caused by teriflunomide in a patient with multiple sclerosis","volume":"57","author":"Kurtuncu","year":"2019","journal-title":"Clin Toxicol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/ijd.13742","article-title":"Teriflunomide-induced psoriasiform changes of fingernails:A new example of paradoxical side effect","volume":"56","author":"Dereure","year":"2017","journal-title":"Int J Dermatol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.msard.2018.11.020","article-title":"Palmar pustular psoriasis associated with teriflunomide treatment","volume":"27","author":"Negrotto","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1177\/1352458515596601","article-title":"Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis","volume":"21","author":"Gerschenfeld","year":"2015","journal-title":"Mult Scler J"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/ced.14339","article-title":"Teriflunomide induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"46","author":"Choudhary","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.msard.2017.09.029","article-title":"Nail loss after teriflunomide treatment:A new potential adverse event","volume":"18","author":"Mancinelli","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"R8-20240828","first-page":"1","article-title":"A case of drug-induced bullous pemphigoid associated with teriflunomide:A patient with relapsing multiple sclerosis","volume":"43","author":"Arslana","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"R9-20240828","first-page":"1","article-title":"Lichenoid drug eruption with prominent nail changes due to leflunomide in a 12-year-old child","volume":"34","author":"Caitlin May","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaad.2018.02.010","article-title":"Lichen planus and lichenoid dermatoses:Clinical overview and molecular basis","volume":"79","author":"Tziotzios","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0001-7310(08)74660-X","article-title":"Lichenoid drug eruption induced by olanzapine","volume":"99","author":"Fern\u00e1ndez-Torres","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jdcr.2017.09.033","article-title":"Giant annular lichenoid drug eruption caused by efavirenz therapy","volume":"4","author":"Baumrin","year":"2018","journal-title":"JAAD Case Rep"},{"key":"R13-20240828","first-page":"32","article-title":"Lichenoid drug reaction developing during the treatment of recurrent chronic hepatitis C","volume":"20","author":"Kronik","year":"2014","journal-title":"Viral Hepat J"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/15569527.2016.1160101","article-title":"Terbinafine induced lichenoid drug eruption","volume":"36","author":"Zheng","year":"2017","journal-title":"Cutan Ocul Toxicol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_27_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:12:42Z","timestamp":1787760762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_27_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_27_23","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"2023-01-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}